The expression of DAD1 in ovarian cancer was reported in OVCAR3 cells following the treatment of cisplatin, indicating that over-expression of DAD1 contributed to the development of cisplatin resistance in ovarian cancer [47]. This evidence concerns the gene DAD1 and ovarian cancer.